Commonwealth Equity Services
UBX

Commonwealth Equity Services’s Unity Biotechnology UBX Stock Holding History

Commonwealth Equity Services’s Portfolio UBX Stock Details UBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-26,142
Closed -$10K – 4434
2025
Q2 		$10K Buy
26,142
+30
+0.1% +$26 ﹤0.01% 4233
2025
Q1 		$27K Buy
26,112
+1,880
+8% +$3.4K ﹤0.01% 4110
2024
Q4 		$24K Buy
24,232
+120
+0.5% +$149 ﹤0.01% 4033
2024
Q3 		$35K Sell
24,112
-500
-2% -$734 ﹤0.01% 3962
2024
Q2 		$33K Hold
24,612
– – ﹤0.01% 3931
2024
Q1 		$40K Buy
24,612
+1,000
+4% +$1.74K ﹤0.01% 3917
2023
Q4 		$46K Sell
23,612
-750
-3% -$1.4K ﹤0.01% 3765
2023
Q3 		$58K Sell
24,362
-10
-0% -$26 ﹤0.01% 3643
2023
Q2 		$62K Sell
24,372
-140
-0.6% -$370 ﹤0.01% 3636
2023
Q1 		$39 Buy
24,512
+8,499
+53% +$34.1K ﹤0.01% 3609
2022
Q4 		$43K Buy
16,013
+11,712
+272% +$34K ﹤0.01% 3528
2022
Q3 		$16K Buy
4,301
+3,014
+234% +$19K ﹤0.01% 3598
2022
Q2 		$7K Sell
1,287
-95
-7% -$793 ﹤0.01% 3639
2022
Q1 		$15K Sell
1,382
-80
-5% -$897 ﹤0.01% 3671
2021
Q4 		$21K Buy
1,462
+392
+37% +$8.57K ﹤0.01% 3597
2021
Q3 		$32K Sell
1,070
-150
-12% -$5.29K ﹤0.01% 3526
2021
Q2 		$56K Buy
+1,220
New +$58.7K ﹤0.01% 3455

Other funds holding UBX

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
AIP
Ameritas Investment Partners Lincoln, Nebraska $3.25B AUM 28.52% 1-Year Est. Return
AWM
AllSquare Wealth Management Albany, New York $189M AUM 14.89% 1-Year Est. Return

Commonwealth Equity Services's UBX Position: Q3 2025 in Review

Commonwealth Equity Services sold out of Unity Biotechnology (UBX) in Q3 2025, closing a stake of 26,142 shares — an estimated $10K sold.

Commonwealth Equity Services first reported a position in UBX in Q2 2021 and held it in 17 quarters. The position peaked at $62K in Q2 2023. 6 funds tracked by Wall St. Rank hold UBX as of Q3 2025.

  • Commonwealth Equity Services reported no remaining Unity Biotechnology position as of Q3 2025 after selling out during the quarter.
  • Commonwealth Equity Services sold 26,142 Unity Biotechnology shares in Q3 2025, an estimated $10K.
  • Commonwealth Equity Services first reported a position in Unity Biotechnology in Q2 2021 and held it in 17 quarters.
  • Commonwealth Equity Services's Unity Biotechnology position peaked at $62K in Q2 2023.
  • 6 funds tracked by Wall St. Rank held Unity Biotechnology as of Q3 2025.

Based on Commonwealth Equity Services's 13F filing for Q3 2025, filed 22 Oct 2025.